MD PhD.Cardiology, Institute of Cardiovascular Diseases & Victor Babes University of Medicine and Pharmacy,Timisoara,Romania. #digitahealth#acutecvd#echofirst
Am onoarea sa va invit la 𝗖𝗼𝗻𝗳𝗲𝗿𝗶𝗻𝘁̦𝗮 𝗜𝗻𝘀𝘁𝗶𝘁𝘂𝘁𝘂𝗹𝘂𝗶 𝗱𝗲 𝗕𝗼𝗹𝗶 𝗖𝗮𝗿𝗱𝗶𝗼𝘃𝗮𝘀𝗰𝘂𝗹𝗮𝗿𝗲 𝗧𝗶𝗺𝗶𝘀̦𝗼𝗮𝗿𝗮 – 𝟭𝟵-𝟮𝟭 𝗼𝗰𝘁𝗼𝗺𝗯𝗿𝗶𝗲 𝟮𝟬𝟮𝟯, https://t.co/RgnIRu0Qe4 #CardioGaita#conference#Cardio#TCC#IBCVTM
#MDPIPharmaceutics 📗
"Arterial Hypertension: Individual Therapeutic Approaches—From DNA Sequencing to Gender Differentiation and New Therapeutic Targets" by Constantin-Tudor Luca et al.
Full paper at https://t.co/xdjjtcpAFs
@escardio@CMichaelGibson#AskMikeGibson
" Taking into account the results of EMPEROR Reduced trial, in compare to last year DAPA HF, which do you consider that would be the better option for patients with reduced HF, dapa or empagliflozin?#escCongress
Thank you.
COMPLICAŢII SAU CAZURI DIFICILE DE ANGIOPLASTIE PRIMARĂ PENTRU #STEMI ~ Moderatori Dr. Ş. Moţ, Dr.I. Nedelciuc ~ Dr.A. Bazyani, Dr.C. Mornoş,Dr.L. Predescu, Dr.O.Anchidin, Dr. R.Şerban~Conferinta de Primavara 2020 ~ https://t.co/Aoqh1enqyw ~ #CNP#GL2020#ROCardio@ESCardioNews
🤩...o zi de poveste!
De poveste cu happy-end in conditiile in care pacientii cu boli CV sau cu risc CV crescut sunt tratati optim, in principal cu triada de preventie: IECA(sartan),statina, antitrombotice + betablocant in caz de IM, ICC sau HTA. #CNP#CardioTwitter@SRCCardio
4D CMR in mixed reality - an integrated useful tool for cardiac imaging, presented in Digital Health stage 2 by Dr. Zlahoda-Huzior
#ESCCongress#ESCdigital
Digital Health Stage 2: the use of digital technologies in the evaluation of risk factors and of their progression, a presentation by Dr. Pushkarev
#ESCcongress#ESCdigital
The importance of artifficial intelligence in cardiac patient evaluation: available data and the importance of clinical reasoning, presented by Dr. R. Mehran
#ESCCongress#ESCDigital
MINOCA: making the difference between myocardial injury and type 2 myocardial infarction, a topic presented by Prof. Filippo Crea
#ESCCongress#ESCDigital